Elucidating clock control of glucocorticoid action
Elucidating clock control of glucocorticoid action
批准号:
MR/N021479/1
负责人:
Ann Louise Hunter
金额:
$34.33万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
糖皮质激素是一种类固醇激素,是广泛使用的抗炎药物,可有效治疗类风湿性关节炎、哮喘、炎症性肠病、多发性硬化症和癌症等疾病。不幸的是,它们的使用受到副作用的限制,这可能是令人痛苦和有害的,服用糖皮质激素的患者报告体重增加、糖尿病、骨质疏松症、失眠和脂肪分布改变等问题。将糖皮质激素的副作用降至最低,同时保持其抗炎作用,是改善这些可获得、廉价和易于管理的药物使用的关键。我的东道主实验室刚刚发现,糖皮质激素药物的作用受到人体内在生物钟的深刻调节。我们的生物钟由光和食物等外部信号编程,在面对外界光线、温度和食物供应的变化时,对于维持身体内部环境至关重要。我们实验室的工作表明,糖皮质激素受体与基因组中与核心时钟蛋白、隐色素(Cry)和Rev-ERB的结合位点密切相关的位置相结合。这提示了一种控制糖皮质激素受体作用的新机制,包括启动或阻止糖皮质激素受体进入其靶点。这种机制打开了一个治疗机会,使糖皮质激素的负面影响可以被靶向,而不会减少它们的有益影响。在我的研究员职位上,我计划调查Cry是否确实可以被利用来减少糖皮质激素的副作用。我还计划研究另一种蛋白质--金属粘附素的作用。胃粘附素(MTDH)是糖皮质激素受体与DNA结合的调节因子,其在肝脏中的表达受昼夜节律控制。我的宿主实验室已经获得了MTDH基因敲除小鼠,在早期的工作中,这些小鼠在体内表现出明显的糖皮质激素表型。我现在将使用这些老鼠来研究昼夜节律的维度。我的假设是,时钟通过隐色素和金属粘附素来调节糖皮质激素的活动。我建议用缺乏Cry或MTDH的小鼠来测试这一点,并测量对急性和慢性糖皮质激素注射的反应。我计划确定隐色素和金属粘附素是否共同作用,并利用这些信息来测试治疗策略,目的是减少糖皮质激素的副作用。
英文摘要
Glucocorticoids, a type of steroid hormone, are widely-used anti-inflammatory drugs which provide effective treatment for conditions such as rheumatoid arthritis, asthma, inflammatory bowel disease, multiple sclerosis and cancer. Unfortunately, their use is limited by side effects, which can be both distressing and harmful, with patients taking glucocorticoids reporting weight gain, diabetes, bone-thinning, insomnia, and altered fat distribution, amongst other problems. Minimising the side effects of glucocorticoids, whilst preserving their anti-inflammatory action, is key to improving the use of these accessible, cheap, and easy-to-administer drugs.My host laboratory has just discovered that the action of glucocorticoid drugs is profoundly regulated by the body's intrinsic circadian clock. Our body clock, programmed by external signals such as light and food, is critical in maintaining the body's internal environment in the face of changing outside light, temperature and food availability. Work from our laboratory shows that the glucocorticoid receptor binds to sites in the genome which are closely related to binding sites for the core clock proteins, Cryptochrome (Cry), and REV-ERB. This suggests a novel mechanism operating to control glucocorticoid receptor action, involving priming, or preventing access of the glucocorticoid receptor to its target sites. Such a mechanism opens a therapeutic opportunity whereby the adverse effects of glucocorticoids could be targeted, without reducing their beneficial effects.In my Fellowship, I plan to investigate whether Cry can indeed be exploited to reduce glucocorticoid side effects. I also plan to investigate the contribution of another protein, Metadherin. Metadherin (MTDH) has just been revealed as a regulator of glucocorticoid receptor binding to DNA, and fascinatingly, MTDH expression in the liver lies under circadian control. My host lab has obtained MTDH knockout mice, and in early work, these show a marked in-vivo glucocorticoid phenotype. I will now investigate the circadian dimension, using these mice.My hypothesis is that the clock acts through Cryptochrome, and Metadherin, to regulate glucocorticoid action. I propose to test this using mice lacking Cry, or MTDH, and measure responses to acute and chronic glucocorticoid administration. I plan to determine whether or not Cryptochrome and Metadherin work together, and to use this information to test therapeutic strategies with the aim of reducing glucocorticoid side effects.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1101/2021.04.10.438998
发表时间:
2021-04
期刊:
bioRxiv
影响因子:
--
作者:
[A. L. Hunter;T. Poolman;Donghwan Kim;F. Gonzalez;D. Bechtold;A. Loudon;M. Iqbal;D. Ray]
通讯作者:
A. L. Hunter;T. Poolman;Donghwan Kim;F. Gonzalez;D. Bechtold;A. Loudon;M. Iqbal;D. Ray
DOI:
10.12688/f1000research.53926.2
发表时间:
2021
期刊:
F1000Research
影响因子:
--
作者:
[Briggs P, Hunter AL, Yang SH, Sharrocks AD, Iqbal M]
通讯作者:
Iqbal M
DOI:
10.1016/j.celrep.2022.110697
发表时间:
2022-04-19
期刊:
CELL REPORTS
影响因子:
8.8
作者:
[Hunter, A. Louise, Poolman, Toryn M., Kim, Donghwan, Gonzalez, Frank J., Bechtold, David A., Loudon, Andrew S., I, Iqbal, Mudassar, Ray, David W.]
通讯作者:
Ray, David W.
DOI:
10.7554/elife.63324
发表时间:
2021-08-05
期刊:
eLife
影响因子:
7.7
作者:
[Hunter AL, Pelekanou CE, Barron NJ, Northeast RC, Grudzien M, Adamson AD, Downton P, Cornfield T, Cunningham PS, Billaud JN, Hodson L, Loudon AS, Unwin RD, Iqbal M, Ray DW, Bechtold DA]
通讯作者:
Bechtold DA
DOI:
10.1172/jci96138
发表时间:
2018-10-01
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[Caratti G, Iqbal M, Hunter L, Kim D, Wang P, Vonslow RM, Begley N, Tetley AJ, Woodburn JL, Pariollaud M, Maidstone R, Donaldson IJ, Zhang Z, Ince LM, Kitchen G, Baxter M, Poolman TM, Daniels DA, Stirling DR, Brocker C, Gonzalez F, Loudon AS, Bechtold DA, Rattray M, Matthews LC, Ray DW]
通讯作者:
Ray DW
国内基金
海外基金
登录
查看更多内容
CLOCK 介导自噬调控鸡肝脏脂质代谢节律稳态的作用机制研究
-
批准号:ZCLQN26C1702
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王攀林
-
依托单位:
CLOCK 下调通过调控染色质可及性抑制WNT 信号在子痈前期滋养细胞分化中的作用及机制
-
批准号:82502036
-
项目类别:青年项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:许祺欣
-
依托单位:
过氧化氢节律通过CLOCK氧化还原修饰调控血管衰老的机制研究
-
批准号:32501040
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:王小满
-
依托单位:
哺乳动物心脏内源性H2O2近日节律振荡通过CLOCK氧化还原修饰维持心脏正常生理功能
-
批准号:82400469
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:李勋凯
-
依托单位:
基于circA1CF介导Clock乙酰化修饰Bmal1-Lys 537残基探讨调周法
改善卵巢生物钟的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:李玉玲
-
依托单位:
SE-lncRNA LMAGA协同CLOCK及YAP1促进胃癌亲淋巴结转移机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:叶耿泰
-
依托单位:
“少阳调枢”穴位埋线法经SPR/MRGPRX2调节BMAL1/CLOCK介导的肥大细胞激活节律改善变应性鼻炎“晨旦骤嚏”的机制研究
-
批准号:82474282
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2024
-
负责人:李昕蓉
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
m6A甲基转移酶METTL3介导气道上皮细胞生物钟基因CLOCK调控哮喘气道炎症的作用机制
-
批准号:82300037
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:王晶
-
依托单位:
Bmal1/Clock介导ARs信号通路对肺叶切除术后房颤的影响及针刺干预作用机制
-
批准号:82374451
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:吴财能
-
依托单位: